Literature DB >> 4672651

Differences in the binding to fibrin of urokinase and tissue plasminogen activator.

S Thorsen, P Glas-Greenwalt, T Astrup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4672651

Source DB:  PubMed          Journal:  Thromb Diath Haemorrh        ISSN： 0340-5338


× No keyword cloud information.
  22 in total

1.  Localization of the binding site of tissue-type plasminogen activator to fibrin.

Authors:  A Ichinose; K Takio; K Fujikawa
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

Review 2.  Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.

Authors:  R Fears
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

3.  Autonomous functions of structural domains on human tissue-type plasminogen activator.

Authors:  A J van Zonneveld; H Veerman; H Pannekoek
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 4.  Basis of antifibrinolytic therapy.

Authors:  C R Prentice
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

5.  The genetic relationships between the kringle domains of human plasminogen, prothrombin, tissue plasminogen activator, urokinase, and coagulation factor XII.

Authors:  F J Castellino; J M Beals
Journal:  J Mol Evol       Date:  1987       Impact factor: 2.395

6.  Thrombolysis of a modified Blalock-Taussig shunt with recombinant tissue plasminogen activator in a newborn infant with pulmonary atresia and ventricular septal defect.

Authors:  M Ries; H Singer; M Hofbeck
Journal:  Br Heart J       Date:  1994-08

7.  Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.

Authors:  S Thorsen; S Müllertz; E Suenson; P Kok
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

8.  Purified plasminogen activating factor produced by malignant lymphoid cells abrogates lymphocyte cytotoxicity.

Authors:  S K Sundar; J Bergeron; J Menezes
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

9.  The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains.

Authors:  T Ny; F Elgh; B Lund
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

10.  Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity.

Authors:  R I Levin; P C Harpel; D Weil; T S Chang; D B Rifkin
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.